Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Mar 13;13(3):247-9.
doi: 10.1016/j.chom.2013.02.012.

RIG-I goes beyond naked recognition

Affiliations
Comment

RIG-I goes beyond naked recognition

J Bradford Bowzard et al. Cell Host Microbe. .

Abstract

It is currently unclear at which point during viral replication that RNA genomes are first recognized as nonself by the immune system. In this issue of Cell Host & Microbe, Weber et al. show that incoming nucleocapsid-bound genomes are sufficient to bind and activate innate immune sensors.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Nature and Availability of RIG-I Ligands during the Virus Replication Cycle
Encapsidated viral RNA with 5′ PPP groups and proper secondary structures for RIG-I recognition are relatively few in number shortly after virus entry. The coated viral RNA (vRNA) interacts with the C-terminal domain of RIG-I to allow activation of RIG-I and association with IPS-1 present on peroxisomes to initiate ISGs mediated early antiviral response. vRNA is replicated and transcribed in the nucleus (in the case of influenza A virus, illustrated here) or in the cytoplasm (many other RNA viruses) to produce abundant messenger RNA (mRNA) (coated or capped?) and vRNA with 5′ PPP (coated?) available for optimal RIG-I activation and IFN production via IPS interaction present on mitochondria. Although RIG-I can be activated by either naked or encapsidated viral RNA, whether the different ligands induce similar or different structural rearrangements (“X” or “Y” conformation) is not clear.

Comment on

References

    1. Cui S, Eisenächer K, Kirchhofer A, Brzózka K, Lammens A, Lammens K, Fujita T, Conzelmann KK, Krug A, and Hopfner KP (2008). Mol. Cell 29, 169–179. - PubMed
    1. Davis WG, Bowzard JB, Sharma SD, Wiens ME, Ranjan P, Gangappa S, Stuchlik O, Pohl J, Donis RO, Katz JM, et al. (2012). PLoS ONE 7, e32661. - PMC - PubMed
    1. Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, et al. (2010). Cell 141, 668–681. - PMC - PubMed
    1. Hornung V, Ellegast J, Kim S, Brzózka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, et al. (2006). Science 314, 994–997. - PubMed
    1. Janeway CA Jr., and Medzhitov R (2002). Annu. Rev. Immunol. 20, 197–216. - PubMed

LinkOut - more resources